Skip to content

ICMR NHRP STEPS-INDIA Multi-Centre Study

Strategies for enhanced population engagement and Health Care Seeking for Prevention and Control of Hypertension and Diabetes in India The STEPS INDIA Multi Centre Study - STEPS INDIA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085098
Enrollment
3900
Registered
2025-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension Health Condition 2: E115- Type 2 diabetes mellitus with circulatory complications

Interventions

Intervention1: HWC Level: Catalyst and Mobilizer: It will act as a drug dispensary and facilitate screening for complications. It will provide follow up health check-ups and referral whenever needed.

Sponsors

ICMR Headquarters
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Taking anti-hypertensive or anti-diabetic drugs Detected as having Hypertension OR Diabetes during screening Detected as having elevated blood pressure Detected as having prediabetes OR impaired glycemia

Exclusion criteria

Exclusion criteria: Consent refusal for participation Planning to migrate out from the cluster during the study period Individuals confined to bed or with severe chronic conditions (Stroke, Chronic kidney disease)

Design outcomes

Primary

MeasureTime frame
1.Identification of potential interventions to engage communities for prevention and control of selected Non communicable diseases.Identification of key stakeholders.2.Development of final model 2 of eCES and communication packages required for implementation of interventions 3.For those below 60 years systolic blood pressure more than 140 mmHg and diastolic blood pressure more than 90 mm Hg. For those above 60 years SBP HbA1c below 7 Methods of measurement.Timepoint: Baseline,12 Months,18 Months

Secondary

MeasureTime frame
Reversal of prehypertension or elevated blood pressure Reversal of prediabetes Improvement in proportion of persons with hypertension who are on treatment Improvement in proportion of persons with diabetes who are on treatment Reduction in prevalence of risk factorsTimepoint: Nine months with three months overlap with phase 2

Countries

India

Contacts

Public ContactDr Abhijit P Pakhare

ICMR

shivashankar.r@icmr.gov.in9312065025

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026